Last updated: February 28, 2026
What are the key excipient components in GOOD SENSE ALL DAY ALLERGY D?
The formulation contains active pharmaceutical ingredients (APIs) alongside excipients designed to improve stability, bioavailability, and patient compliance. The primary components include:
- Main API: Loratadine, a non-sedating antihistamine.
- Excipients:
- Lactose monohydrate: Used as a filler or diluent.
- Microcrystalline cellulose: Provides tablet structural integrity.
- Corn starch: Disintegrant facilitating tablet breakup.
- Croscarmellose sodium: Super-disintegrant to enhance dissolution.
- Magnesium stearate: Lubricant aiding tablet manufacturing.
- Titanium dioxide (E171): Opacifier for tablet color.
The formulation aims to optimize fast onset and sustained effect with minimal excipient-related intolerance.
How does excipient selection influence product performance?
The selection impacts multiple dimensions:
- Stability: Lactose and titanium dioxide preserve tablet integrity.
- Disintegration and dissolution: Corn starch and croscarmellose sodium ensure rapid release.
- Manufacturing consistency: Microcrystalline cellulose and magnesium stearate promote uniformity.
- Sensory attributes: Coloring agents like titanium dioxide affect appearance without altering efficacy.
These choices balance manufacturability, patient safety, and therapeutic performance.
What are current trends and challenges in excipient strategies?
Trends:
- Use of plant-based, non-allergenic excipients to reduce adverse reactions.
- Incorporation of multifunctional excipients to minimize formulation complexity.
- Transition to excipients with better sustainability profiles.
Challenges:
- Regulatory restrictions on certain excipients, e.g., titanium dioxide's recent evaluation as a possible carcinogen.
- Variability in excipient sourcing affecting batch consistency.
- Need for compatibility assessments with APIs and other formulation components.
What commercial opportunities exist through excipient innovation?
Opportunities include:
- Developing allergen-free or hypoallergenic excipient systems, targeting sensitive patient populations.
- Using novel disintegrants or binders to enable smaller, more convenient dosage forms.
- Formulating with excipients optimized for extended shelf life, reducing waste.
Companies that innovate with excipient composition can differentiate products via improved safety profiles, patient adherence, and regulatory compliance.
How can excipient choices impact regulatory and market access?
Regulatory focus on excipient safety increasingly influences product approval. Clear documentation of excipient safety profiles, especially regarding allergenic potential, accelerates review processes. Markets with strict regulations on certain excipients, such as the EU's restrictions on titanium dioxide, prompt formulation adjustments to maintain market access.
What are the key considerations for licensing and patent strategies?
Formulation patents often cover specific excipient combinations or processing methods. Innovating excipient composition can extend patent life and prevent generic competition. Licensing opportunities arise from proprietary excipient blends, especially those that enhance product stability or tolerability.
Summary of commercial implications
- Excipient innovation can significantly enhance product differentiation.
- Regulatory shifts may require reformulation, presenting both risk and opportunity.
- Supply chain stability for excipients influences manufacturing reliability and costs.
Adoption of new excipients or formulations tailored to regulatory environments can unlock premium market segments and extend product lifecycle.
Key Takeaways
- Excipients like lactose, microcrystalline cellulose, and corn starch are foundational to GOOD SENSE ALL DAY ALLERGY D.
- Innovations in excipient composition, especially hypoallergenic or sustainable options, offer differentiation and regulatory advantages.
- Regulatory trends, especially regarding titanium dioxide, influence formulation strategies.
- Formulation patents based on excipient combinations provide protective barriers and licensing avenues.
- Supply chain management of excipients affects manufacturing, costs, and compliance.
FAQs
1. Which excipients in GOOD SENSE ALL DAY ALLERGY D may present allergenic risks?
Lactose and corn starch are potential allergens for lactose-intolerant and corn-sensitive individuals, respectively. Choosing alternative excipients can mitigate this.
2. How does the regulatory environment influence excipient choice?
Stricter evaluations, such as the EU's review of titanium dioxide, require reformulation to comply with safety standards, affecting available excipients.
3. Are there sustainable excipient options for antihistamine formulations?
Yes. Plant-based, non-GMO excipients and those derived from renewable resources can replace synthetic or mineral sources.
4. What are the benefits of using multifunctional excipients?
They reduce formulation complexity, simplify manufacturing, decrease costs, and can improve product attributes like stability and bioavailability.
5. How can excipient innovation extend a product’s lifecycle?
Novel excipients can enable new formulations, improve performance, and support patent extensions, delaying generic entry.
References
[1] U.S. Food and Drug Administration. (2022). Excipient information and safety analysis.
[2] European Medicines Agency. (2021). Review of titanium dioxide as a food additive and pharmaceutical excipient.
[3] Shah, N., & Vora, J. (2020). Excipient selection and formulation optimization in pharmaceuticals. Journal of Pharmaceutical Sciences.
